ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 118 filers reported holding ACCELERON PHARMA INC in Q1 2015. The put-call ratio across all filers is 0.99 and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $605,000 | -95.6% | 24,314 | -93.3% | 0.85% | -60.6% |
| Q1 2015 | $13,821,000 | +4.9% | 363,136 | +7.4% | 2.15% | +18.3% |
| Q4 2014 | $13,172,000 | +2399.4% | 338,082 | +2081.2% | 1.82% | +2423.6% |
| Q2 2014 | $527,000 | -88.8% | 15,500 | -88.6% | 0.07% | -90.8% |
| Q1 2014 | $4,707,000 | +463.7% | 136,423 | +263.2% | 0.78% | +450.0% |
| Q3 2013 | $835,000 | – | 37,557 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 917,767 | $52,524,000 | 8.19% |
| Foresite Capital Management II, LLC | 220,268 | $12,606,000 | 4.66% |
| Foresite Capital Management III, LLC | 250,863 | $14,357,000 | 3.17% |
| Novo Holdings A/S | 650,000 | $37,200,000 | 2.95% |
| QVT Financial LP | 190,977 | $10,930,000 | 2.82% |
| Perceptive Advisors | 1,528,205 | $87,459,000 | 2.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,117,651 | $63,963,000 | 2.29% |
| Asymmetry Capital Management, L.P. | 39,912 | $2,284,000 | 2.11% |
| SECTORAL ASSET MANAGEMENT INC | 298,726 | $17,096,000 | 1.82% |
| Stanley-Laman Group, Ltd. | 125,020 | $7,155,000 | 1.76% |